Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Asthma (Disease Or Phenotype)

Omim:MTHU005153

Nci:C28397

Msh:D001249

Mondo:MONDO:4979

Medcin:MEDCIN:32881

Mdr:MDR:10003560

Lnc:MTHU020815

Id:c389c315-d1ef-50bd-a16e-6677b3bcd143

Icpc2icd10eng:MTHU008836

Icd10cm:J45.90

Doid:DOID:2841

Chv:CHV:1541

Results found

Linked to

	Label	Description
	Pirbuterol indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Desonide indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Tranilast indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisone indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	zafirlukast indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	terbutaline indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-methylxanthine correlated with condition Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Reproterol indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pirbuterol indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Desonide indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Tranilast indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisone indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

zafirlukast indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

terbutaline indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

1-methylxanthine correlated with condition Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Reproterol indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.